ArticleOncotarget2019

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors.

Irene Veneziani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.